Relationship of serum and cerebrospinal fluid biomarkers with intracranial hypertension and cerebral hypoperfusion after severe traumatic brain injury

Journal of Trauma - Injury, Infection and Critical Care

Volumn 70, Issue 5, 2011, Pages 1096-1103

  Stein, Deborah M ^a,b,c   Lindell, Allison ^b   Murdock, Karen R ^b   Kufera, Joseph A ^b   Menaker, Jay ^a,b   Keledjian, Kaspar ^b   Bochicchio, Grant V ^a,b   Aarabi, Bizhan ^a   Scalea, Thomas M ^a,b  

^a R ADAMS COWLEY SHOCK TRAUMA CENTER   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

Biomarkers; Cerebral hypoperfusion; Intracranial hypertension; Neuroinflammation; Traumatic brain injury

Indexed keywords

INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 8; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGED; ARTICLE; BIOLOGICAL MONITORING; BRAIN PERFUSION; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; CLINICAL TRIAL; CORRELATION ANALYSIS; DISEASE MARKER; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; INTRACRANIAL HYPERTENSION; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SERODIAGNOSIS; TRAUMATIC BRAIN INJURY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL MARKERS; BRAIN INJURIES; BRAIN ISCHEMIA; CEREBROVASCULAR CIRCULATION; CYTOKINES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTRACRANIAL HYPERTENSION; INTRACRANIAL PRESSURE; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; TRAUMA SEVERITY INDICES; YOUNG ADULT;

EID: 79955770615     PISSN: 00225282     EISSN: 15298809     Source Type: Journal    
DOI: 10.1097/TA.0b013e318216930d     Document Type: Article

References (69)

1. Langlois J, Rutland-Brown W, Wald M. The epidemiology and impact of traumatic brain injury: a brief overview. J Head Trauma Rehabil. 2006;21:375-378. (Pubitemid 44413110)
2. Kraus JF, MacArthur DL, Silverman TA, et al. Epidemiology of brain injury. Neurotrauma. 1996:13-30.
3. Ghajar J. Traumatic brain injury. Lancet. 2000;356:923-929.
4. Dutton RP, Stansbury LG, Leone S, Kramer E, Hess JR, Scalea TM. Trauma mortality in mature trauma systems: are we doing better? An analysis of trauma mortality patterns, 1997-2008. J Trauma. 2010;69: 620-626.
5. Thurman DJ, Alverson C, Dunn KA, Guerrero J, Sniezek JE. Traumatic brain injury in the United States: a public health perspective. J Head Trauma Rehabil. 1999;14:602-615. (Pubitemid 30027268)
6. Chestnut RM, Marshall LF, Klauber MR, et al. The role of secondary brain injury in determining outcome from severe head injury. J Trauma. 1993;34:216-222. (Pubitemid 23111023)
7. Stocchetti N, Furlan A, Volta F. Hypoxemia and arterial hypotension at the accident scene in head injury. J Trauma. 1996;40:764-767. (Pubitemid 26142760)
8. Bratton SL, Chestnut RM, Ghajar J, et al. Guidelines for the management of severe traumatic brain injury. J Neurotrauma. 2007;24(Suppl 1):S37-S44.
9. Eisenberg HM, Frankowski RF, Contant CF, Marshall LF, Walker MD. High dose barbituate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg. 1988;69:15-23.
10. Narayan R, Kishore P, Becker D, et al. Intracranial pressure: to monitor or not to monitor? A review of our experience with head injury. J Neurosurg. 1982;56:650-659. (Pubitemid 12095044)
11. Changaris DG, McGraw CP, Richardson JD, Garretson HD, Arpin EJ, Shields CB. Correlation of cerebral perfusion pressure and Glasgow Coma Scale to outcome. J Trauma. 1987;27:1007-1013. (Pubitemid 17162675)
12. Schreiber MA, Aoki N, Scott BG, Beck JR. Determination of mortality in patients with severe blunt head injury. Arch Surg. 2002;137:285-290. (Pubitemid 34207987)
13. Robertson CS, Valadka AB, Hannay HJ, et al. Prevention of secondary ischemic insults after severe head injury. Crit Care Med. 1999;27:2086-2095. (Pubitemid 29508318)
14. Flierl MA, Stoneback JW, Beauchamp KM, et al. Femur shaft fracture fixation in head-injured patients: when is the right time? J Orthop Trauma. 2010;24:107-114.
15. Scalea TM. Optimal timing of fracture fixation: have we learned anything in the past 20 years? J Trauma. 2008;65:253-260.
16. Goodman MD, Makley AT, Lentsch AB, et al. Traumatic brain injury and aeromedical evacuation: when is the brain fit to fly? J Surg Res. 2010;164:286-293.
17. Bridges E, Biever K. Advancing critical care: joint combat casualty research team and joint theater trauma system. AACN Adv Crit Care. 2010;21:260-276.
18. Kennedy CS, Moffatt M. Acute traumatic brain injury in children: exploring the cutting edge in understanding, therapy, and research. Clin Pediatr Emerg Med. 2004;5:224-238.
19. Vos PE, Lamers KJ, Hendriks JC, et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology. 2004;62:1303-1310. (Pubitemid 38526041)
20. Miller JD, Sweet RC, Narayan R, Becker DP. Early insults to the injured brain. JAMA. 1978;240:439-432.
21. Signorini DF, Andrews PJ, Jones PA, Wardlaw JM, Miller JD. Adding insult to injury: the prognostic value of early secondary insults to survival after traumatic brain injury. J Neurol Neurosurg Psychiatry. 1999;66:26-31. (Pubitemid 29101482)
22. Chambers IR, Treadwell L, Mendelow AD. The cause and incidence of secondary insults in severely head-injured adults and children. Br J Neurosurg. 2000;14:424-431.
23. Morganti-Kossmann MC, Satgunaseelan L, Bye K, Kossmann T. Modulation of immune response by head injury. Injury. 2007;38:1392-1400. (Pubitemid 350192405)
24. Cederberg D, Siesjö. What has inflammation to do with traumatic brain injury? Childs Nerv Syst. 2010;26:221-226.
25. Lucas S, Rothwell NJ, Gibson RM. The role of inflammation in CNS injury and disease. Br J Pharmacol. 2006;147:232-240.
26. Morganti-Kossmann MC, Rancan M, Otto VI, Kossmann T. Role of cerebral inflammation after traumatic brain injury: a revised concept. Shock. 2001;16:165-177. (Pubitemid 33598193)
27. Chiaretti A, Genovese O, Aloe L, et al. Interleukin-1 beta and interleukin 6 relationship with paediatric head trauma severity and outcome. Childs Nerv Syst. 2005;32:185-193[discussion 194]. (Pubitemid 40378394)
28. Shiozaki T, Hayakata T, Tasaki O, et al. Cerebrospinal fluid concentrations of anti-inflammatory mediators in early-phase severe traumatic brain injury. Shock. 2005;23:406-410. (Pubitemid 40571662)
29. Kita T, Liu L, Tanaka N, Kinoshita Y. The expression of tumor necrosis factor-alpha in the rat brain after fluid percussive injury. Int J Legal Med. 1997;110:305-311. (Pubitemid 27475675)
30. Ross SA, Halliday MI, Campbell GC, Byrnes DP, Rowlands BJ. The presence of tumour necrosis factor in CSF and plasma after severe head injury. Br J Neurosurg. 1994;8:419-425. (Pubitemid 24282529)
31. Goodman JC, Robertson CS, Grossman RG, Narayan RK. Elevation of tumor necrosis factor in head injury. J Neuroimmunol. 1990;30:213-217. (Pubitemid 20362754)
32. Singhal A, Baker AJ, Hare GM, Reinders FX, Schlichter LC, Moulton RJ. Association between cerebrospinal fluid interleukin-6 concentration and outcome after severe human traumatic brain injury. J Neurotrauma. 2002;19:929-937.
33. Winter CD, Pringle AK, Clough GF, Church MK. Raised parenchymal interleukin-6 levels correlate with improved outcome after traumatic brain injury. Brain. 2004;127:315-320. (Pubitemid 38160316)
34. Hayakata T, Shiozaki T, Tasaki O, et al. Changes in CSF S100B and cytokine concentrations in early-phase severe traumatic brain injury. Shock. 2004;22:102-107. (Pubitemid 40228186)
35. Kossman T, Stahel PF, Lenzlinger PM, et al. Interleukin-8 released into the cerebrospinal fluid after brain injury is associated with blood-brain barrier dysfunction and nerve growth factor production. J Cereb Blood Flow Metab. 1997;17:280-289. (Pubitemid 27161371)
36. Ehrlich LC, Hu S, Sheng WS, et al. Cytokine regulation of human microglial cell IL-8 production. J Immunol. 1998;160:1944-1948. (Pubitemid 28106484)
37. Whalen MJ, Carlos TM, Kochanek PM, et al. Interleukin-8 is increased in cerebrospinal fluid of children with severe head injury. Crit Care Med. 2000;28:929-934. (Pubitemid 30262057)
38. Ott L, McClain CJ, Gillespie M, Young B. Cytokines and metabolic dysfunction after severe head injury. J Neurotrauma. 1994;11:447-472. (Pubitemid 24347270)
39. Taşçi A, Okay O, Gezici AR, Ergün R, Ergüngör F. Prognostic value of interleukin-1 beta levels after acute brain injury. Neurol Res. 2003;25: 871-874. (Pubitemid 37499725)
40. Woiciechowsky C, Schöning B, Cobanov J, Lanksch WR, Volk HD, Döcke WD. Early IL-6 plasma concentrations correlate with severity of brain injury and pneumonia in brain-injured patients. J Trauma. 2002; 52:339-345. (Pubitemid 34183803)
41. Maier B, Schwerdtfeger K, Mautes A, et al. Differential release of interleukins 6, 8, and 10 in cerebrospinal fluid and plasma after traumatic brain injury. Shock. 2001;15:421-426. (Pubitemid 33605135)
42. Gopcevic A, Mazul-Sunko B, Marout J, et al. Plasma interleukin-8 as a potential predictor of mortality in adult patients with severe traumatic brain injury. Tohoku J Exp Med. 2007;211:387-393. (Pubitemid 46585552)
43. Kushi H, Saito T, Makino K, Hayashi N. IL-8 is a key mediator of neuroinflammation after traumatic brain injury. Acta Neurochir Suppl. 2003;86:347-350.
44. Mussack T, Biberthaler P, Kanz KG, et al. Serum S-100B and interleukin-8 as predictive markers for comparative neurologic outcome analysis of patients after cardiac arrest and severe traumatic brain injury. Crit Care Med. 2002;30:2669-2674. (Pubitemid 36870568)
45. McKeating EG, Andrews PJ, Signorini DF, Mascia L. Transcranial cytokine gradients in patients requiring intensive care after acute brain injury. Br J Anaesth. 1997;78:520-523. (Pubitemid 27226363)
46. Wilson JT, Pettigrew LE, Teasdale GM. Structured interviews for the Glasgow outcome scale and the extended Glasgow outcome scale: guidelines for their use. J Neurotrauma. 1998;15:573-585.
47. Joseph DK, Dutton RP, Aarabi B, Scalea TM. Decompressive laparotomy to treat intractable intracranial hypertension after traumatic brain injury. J Trauma. 2004;57:687-693.
48. Scalea TM, Bochicchio GV, Habashi N, et al. Increased intra-abdominal, intrathoracic, and intracranial pressure after severe brain injury: multiple compartment syndrome. J Trauma. 2007;62:647-656. (Pubitemid 46568867)
49. Kahraman S, Hu P, Xiao Y, et al. Pressure-time dose of automated ICP and CPP data predicts outcomes in severe TBI. J Trauma. 2010;69:110-118.
50. Vik A, Nag T, Fredriksli OA, et al. Relationship of "dose" of intracranial hypertension to outcome in severe traumatic brain injury. J Neurosurg. 2008;109:678-684.
51. Fan L, Young PR, Barone FC, Feuerstein GZ, Smith DH, McIntosh TK. Experimental brain injury induces expression of interleukin-1 beta mRNA in the rat brain. Brain Res Mol Brain Res. 1995;30:125-130.
52. Yatsiv I, Morganti-Kossmann MC, Perez D, et al. Elevated intracranial IL-18 in humans and mice after traumatic brain injury and evidence of neuroprotective effects of IL-18-binding protein after experimental closed head injury. J Cereb Blood Flow Metab. 2002;22:971-978. (Pubitemid 34831603)
53. Van der Meer JW, Vogels MT, Netea MG, Kullberg BJ. Proinflammatory cytokines and treatment of disease. Ann NY Acad Sci. 1998;856: 243-251. (Pubitemid 28517355)
54. Arvin B, Neville LF, Barone FC, Feuerstein GZ. The role of inflammation and cytokines in brain injury. Neurosci Biobehav Rev. 1996;20:445-452. (Pubitemid 26313703)
55. Tilg H, Dinarello CA, Mier JW. IL-6 and APPs: anti-inflammatory and immunosuppressive mediators. Immunol Today. 1997;18:428-432. (Pubitemid 27381984)
56. Lotz M. Interleukin-6. Cancer Invest. 1993;11:732-742. (Pubitemid 23361109)
57. Jawa RS, Kulaylat MN, Baumann H, Dayton MT. What is new in cytokine research related to trauma/critical care. J Intensive Care Med. 2006;21:63-85.
58. Csuka E, Morganti-Kossmann MC, Lenzlinger PM, Joller H, Trentz O, Kossmann T. IL-10 levels in cerebrospinal fluid and serum of patients with severe traumatic brain injury: relationship to IL-6, TNF-alpha, TGF-beta1 and blood-brain barrier function. J Neurolimmunol. 1999; 101:211-221. (Pubitemid 29516464)
59. Hergenroeder GW, Moore AN, McCoy JP, et al. Serum IL-6: a candidate biomarker for intracranial pressure evaluation following isolated traumatic brain injury. J Neuroinflammation. 2010;7:1-19.
60. Adrie C, Adib-Conquy M, Laurent I, et al. Successful cardiopulmonary resuscitation after cardiac arrest as a "sepsis-like" syndrome. Circulation. 2002;106:562-568. (Pubitemid 34827705)
61. Knoblach SM, Fan L, Faden AI. Early neuronal expression of tumor necrosis factor-alpha after experimental brain injury contributes to neurological impairment. J Neuroimmunol. 1999;95:115-125. (Pubitemid 29173028)
62. Kremlev SG, Palmer C. Interleukin-10 inhibits endotoxin-induced proinflammatory cytokines in microglial cell cultures. J Neuroimmunol. 2005;162:71-80.
63. Dziurdzik P, Krawczyk L, Jalowiecki P, Kondera-Anasz Z, Menon L. Serum interleukin-10 in ICU patients with severe acute central nervous system injuries. Inflamm Res. 2004;53:338-343. (Pubitemid 39141747)
64. Shohami E, Ginis I, Hallenbeck JM. Dual role of tumor necrosis factor alpha in brain injury. Cytokine Growth Factor Rev. 1999;10:119-130. (Pubitemid 29446376)
65. Faber-Elman A, Lavie V, Schvartz I, Shaltiel S, Schwartz M. Vitronectin overrides a negative effect of TNF-alpha on astrocyte migration. FASEB J. 1995;9:1605-1613.
66. Rosenberg GA, Estrada EY, Dencoff JE, Stetler-Stevenson WG. Tumor necrosis factor-alpha-induced gelatinase B causes delayed opening of the blood-brain barrier: an expanded therapeutic window. Brain Res. 1995;703:151-155. (Pubitemid 3013581)
67. Tchélingérian JL, Monge M, Le Saux F, Zalc B, Jacque C. Differential oilgodendroglial expression of the tumor necrosis factor receptors in vivo and in vitro. J Neurochem. 1995;65:1377-2380.
68. Maier B, Lehnert M, Laurer HL, Mautes AE, Steudel WI, Marzi I. Delayed elevation of soluble tumor necrosis factor receptors P75 and P55 in cerebrospinal fluid and plasma after traumatic brain injury. Shock. 2006;26:122-127. (Pubitemid 44162496)
69. Goodman JC, Robertson CS, Grossman RG, Narayan RK. Elevation of tumour necrosis factor in head injury. J Neuroimmunol. 1990;30:213-217. (Pubitemid 20362754)